This is the authors' abstract. We don't add key points for this paper.
Cancer development and progression is associated with aberrant changes in cellular glycosylation. Cells expressing altered glycan-structures are recognized by cells of the immune system, favoring the induction of inhibitory immune processes which subsequently promote tumor growth and spreading. Here, we discuss about the importance of glycobiology in modern medicine, taking into account the impact of altered glycan structures expressed in cancer cells as potential glycobiomarkers of disease, as well as on cancer development and progression.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Reis et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: